Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 22, 2021

SELL
$13.77 - $21.66 $463,980 - $729,833
-33,695 Closed
0 $0
Q4 2020

Jan 27, 2021

BUY
$10.75 - $14.91 $537 - $745
50 Added 0.15%
33,695 $455,000
Q2 2020

Jul 24, 2020

BUY
$10.34 - $15.51 $26,522 - $39,783
2,565 Added 8.25%
33,645 $481,000
Q3 2019

Oct 30, 2019

BUY
$21.01 - $28.94 $26,787 - $36,898
1,275 Added 4.28%
31,080 $779,000
Q2 2019

Jul 24, 2019

BUY
$23.33 - $28.3 $30,328 - $36,790
1,300 Added 4.56%
29,805 $843,000
Q1 2019

Apr 26, 2019

BUY
$14.93 - $25.1 $28,665 - $48,192
1,920 Added 7.22%
28,505 $698,000
Q4 2018

Jan 22, 2019

BUY
$12.68 - $19.01 $33,855 - $50,756
2,670 Added 11.16%
26,585 $416,000
Q3 2018

Oct 26, 2018

SELL
$13.1 - $16.35 $847,635 - $1.06 Million
-64,705 Reduced 73.01%
23,915 $358,000
Q2 2018

Jul 19, 2018

SELL
$13.65 - $18.7 $1,638 - $2,244
-120 Reduced 0.14%
88,620 $1.29 Million
Q1 2018

Apr 12, 2018

BUY
$14.85 - $24.3 $11,731 - $19,197
790 Added 0.9%
88,740 $1.41 Million
Q3 2017

Oct 13, 2017

BUY
$15.5 - $19.15 $1.36 Million - $1.68 Million
87,950
87,950 $1.57 Million

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $5.63B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track James Investment Research Inc Portfolio

Follow James Investment Research Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of James Investment Research Inc, based on Form 13F filings with the SEC.

News

Stay updated on James Investment Research Inc with notifications on news.